Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00817999Phase 4Completed
Phase 4, randomised, open-label trial of clopidogrel in thrombosis (2 arms), sponsored by Creighton University. Primary endpoint: Percentage of Platelet Aggregation Inhibition at 6 hours. Started Nov 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00817999.